Network Bio
Builds AI models trained on patient tissue and clinical data for disease diagnostics
$50MStrategic
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Builds AI models trained on patient tissue and clinical data for disease diagnostics
Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology
Uses cells as sensors to uncover first-in-class medicines
Pitching Breyer Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room